From NAL, date: 6 Jan. 2003.
"The Clinical studies relating to Bone Marrow Transplantation (now more often involving the less invasive blood haemopoietic stem cell transplantation) have progressed extremely well.
Although the preliminary data from those studies has not, for commercial reasons, been published at this time, there has been considerable interest created amongst the specialist clinical fraternity.
Norwood scientists have been approached by 5 of the most significant hospitals/clinical groups in the World. Four of these centres are based in the USA".
_______________________
Comment:
"Preliminary data cannot for commercial reasons be published just now".
Gerry
- Forums
- ASX - By Stock
- NAL
- + +where is nal heading?+ +
+ +where is nal heading?+ +, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online